As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Sir Alec Shelbrooke said he has struggled with his weight throughout his life. A Conservative former minister said he has ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

A study has suggested that weight-loss injections may be linked to broader health benefits ... discovered that participants who used drugs such as Wegovy and Ozempic had a lower risk of 42 health ...

In the middle of September I started taking Wegovy, and in that time I have ... Sir Alec said around 500,000 people are using weight-loss injections and acknowledged some have experienced negative ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.

A study has suggested that weight-loss injections may be linked to broader ... discovered that participants who used drugs such as Wegovy and Ozempic had a lower risk of 42 health conditions ...